Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-4-14
pubmed:abstractText
We have used in vitro oligodendrocyte differentiation and the in vivo remyelination model, the cuprizone model, to identify genes regulating oligodendrocyte function and remyelination. One of the genes we identified, osteopontin (opn), is a secreted glycoprotein with cytokine-like, chemotactic, and anti-apoptotic properties that contains an Arg-Gly-Asp (RGD) cell adhesion motif-mediating interactions with several integrins. Both microglia and astrocytes in demyelinating brain regions of cuprizone-fed mice expressed OPN protein. Recombinant OPN protein produced in a baculovirus expression system induced proliferation of both the rat CG-4 and the mouse Oli-neu oligodendrocyte precursor (OLP)-like cell lines in a dose-dependent manner. In addition, recombinant OPN treatment stimulated both myelin basic protein (MBP) synthesis and myelin sheath formation in mixed cortical cultures from embryonic mouse brain, an in vitro primary culture model of myelination. Interestingly, myelinating mixed cultures prepared from OPN(-/-) mice contained significantly less MBP compared to wild-type cultures after 17 days in culture. We propose that in the central nervous system, OPN may act as a novel regulator of myelination and remyelination.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1044-7431
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
707-21
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15080898-Animals, pubmed-meshheading:15080898-Astrocytes, pubmed-meshheading:15080898-Brain, pubmed-meshheading:15080898-Cell Division, pubmed-meshheading:15080898-Cells, Cultured, pubmed-meshheading:15080898-Coculture Techniques, pubmed-meshheading:15080898-Cuprizone, pubmed-meshheading:15080898-Demyelinating Diseases, pubmed-meshheading:15080898-Disease Models, Animal, pubmed-meshheading:15080898-Female, pubmed-meshheading:15080898-Gene Expression Regulation, Developmental, pubmed-meshheading:15080898-Mice, pubmed-meshheading:15080898-Mice, Inbred C57BL, pubmed-meshheading:15080898-Mice, Knockout, pubmed-meshheading:15080898-Microglia, pubmed-meshheading:15080898-Myelin Proteins, pubmed-meshheading:15080898-Myelin Sheath, pubmed-meshheading:15080898-Nerve Regeneration, pubmed-meshheading:15080898-Oligodendroglia, pubmed-meshheading:15080898-Osteopontin, pubmed-meshheading:15080898-Rats, pubmed-meshheading:15080898-Recombinant Fusion Proteins, pubmed-meshheading:15080898-Sialoglycoproteins, pubmed-meshheading:15080898-Stem Cells, pubmed-meshheading:15080898-Up-Regulation
pubmed:year
2004
pubmed:articleTitle
Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
pubmed:affiliation
Department of Immunology, Serono Pharmaceutical Research Institute, Ares-Serono International SA, Geneva, Switzerland.
pubmed:publicationType
Journal Article